• Merck pneumococcal vaccine lands FDA nod, keeping up competition with Pfizer

    17 days ago - By MedCity News

    Vaxneuvance, a Merck pneumococcal vaccine, is now approved by the FDA. The intramuscular shot protects against 15 pneumococcal strains-five fewer than the 20 covered by a Pfizer pneumococcal vaccine that the FDA approved in June.
    Read more ...